Related Experiment Video

Updated: Dec 25, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.4K

Complete Revascularization in Patients With STEMI and Multi-Vessel Disease: A Meta-Analysis of Randomized Controlled

Ahmad Al-Abdouh1, Mahmoud Barbarawi2, Anas Bizanti1

  • 1Department of Medicine, Saint Agnes Hospital, Baltimore, MD, United States of America.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|April 4, 2020
PubMed

Insights

Complete revascularization significantly lowers major adverse cardiovascular events and cardiovascular mortality in ST-elevation myocardial infarction (STEMI) patients with multivessel disease. This approach should be considered for better patient outcomes following PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI).
  • The optimal revascularization strategy (complete vs. culprit-only) in STEMI patients with multivessel disease is not well-defined.
  • This meta-analysis evaluates the efficacy and safety of complete versus culprit-only revascularization in STEMI.

Purpose of the Study:

  • To compare the effectiveness of complete versus culprit-only revascularization in STEMI patients with multivessel disease.
  • To assess the impact on major adverse cardiovascular events (MACE) and other clinical outcomes.
  • To inform clinical decision-making regarding revascularization strategies in STEMI.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials was conducted.
  • Searches were performed in PubMed/MEDLINE and the Cochrane library.
  • Primary endpoint was MACE; secondary outcomes included mortality, MI, repeat revascularization, stroke, bleeding, and contrast-induced nephropathy.

Main Results:

  • Twelve trials including 7592 patients were analyzed.
  • Complete revascularization significantly reduced MACE (HR 0.61), cardiovascular mortality (HR 0.74), and repeat revascularization (HR 0.43).
  • No significant differences were observed for MI, all-cause mortality, heart failure, major bleeding, stroke, or contrast-induced nephropathy.

Conclusions:

  • Complete revascularization in STEMI patients with multivessel disease is associated with significantly lower risks of MACE, cardiovascular mortality, and repeat revascularization.
  • These findings support the consideration of complete revascularization as a strategy for STEMI patients with multivessel disease.
  • Further research may explore optimal timing and techniques for complete revascularization.
Abstract

Keywords:
And STEMICompleteCulpritRevascularization

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.1K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.1K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
180
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
146
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
265
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
180